(Joshua Paladino, Headline USA) A leading and highly-respected UK medical watchdog recently published a complaint from a children’s rights organization that claimed Pfizer CEO Albert Bourla promoted vaccines for minors without sufficient scientific evidence.
The group UsForThem, which advocates for children’s wellbeing to come first in public policy decisions, filed the complaint against Bourla for the “disgracefully misleading” and “extremely promotional” comments he made about the COVID-19 vaccine for kids, ZeroHedge reported. A panel convened by the influential UK Prescription Medicines Code of Practice Authority agreed and published the complaint.
In an interview with BBC Breakfast in December 2021, Bourla first sowed fear about COVID-19 “thriving” in schools, despite children rarely catching the disease or suffering serious side effects from it.
Implicitly recognizing that COVID-19 does not threaten most children, he argued that childhood vaccination would give “indirect protection” to adults.
“This is disturbing, significantly, the educational system, and there are kids that will have severe symptoms,” he said, adding that “there is no doubt in my mind that the benefits, completely, are in favour of” vaccinating five-year-old children.
“So, that’s the balance — we clearly want to protect children as much as possible and we’ve got good evidence now that this vaccine, even at a low dose, produces a really good protective immune response in children and produces many fewer side effects because of the lower dose,” Bourla said.
UsForThem argued that Bourla’s public statements did not align with the scientific evidence but with Pfizer’s profit motive, according to reporting by American Thinker.
“There is simply no evidence that healthy schoolchildren in the UK are at significant risk from the SARS COV-2 virus,” the group said in the complaint.
Three months after the interview, data showed that childhood COVID-19 vaccination was only 12% effective a few weeks after the shot was given.
A panel of the UK Prescription Medicines Code of Practice Authority agreed that Bourla and Pfizer had violated health codes by misinforming the public, making claims without evidence, and making claims disproportionate to the evidence.
Pfizer appealed the decision, but the PMCPA maintained the central charges.
